Darcy A. Kerr
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 10
- Rheumatology top 5%
- Bone Tumor Diagnosis and Treatments 20
- Soft tissue tumor case studies 10
- Oncology top 5%
-
- Sarcoma Diagnosis and Treatment 31
- Oral Surgery top 5%
- Oral and Maxillofacial Pathology 10
-
- Tumors and Oncological Cases 15
-
- Salivary Gland Tumors Diagnosis and Treatment 14
-
- Thyroid Cancer Diagnosis and Treatment 13
- Co-authors
- Andrew E. RosenbergBreelyn A. WilkyTy K. SubhawongJonathan C. TrentG. Petur NielsenDespina S. KoloniasKonstantinos LinosMatteo Trucco
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesAustriaSwitzerland
In The Last Decade
Darcy A. Kerr
105 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Otorhinolaryngology 138
- Rheumatology 266
- Oncology 472
- Pulmonary and Respiratory Medicine 539
- Oral Surgery 89
Countries citing papers authored by Darcy A. Kerr
This map shows the geographic impact of Darcy A. Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darcy A. Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darcy A. Kerr more than expected).
Fields of papers citing papers by Darcy A. Kerr
This network shows the impact of papers produced by Darcy A. Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darcy A. Kerr. The network helps show where Darcy A. Kerr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Darcy A. Kerr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 0 | |
| 14 | 2022 | 5 | |
| 15 | 2022 | 4 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 1 | |
| 18 | 2020 | 3 | |
| 19 | 2020 | 6 | |
| 20 | A Phase I, open-label study with escalating doses of intravenous PTK787/ZK 222584, a multi-VEGF receptor inhibitor, followed by multiple oral daily dosing to assess the absolute bioavailability of PTK787/ZK 222584 after single and multiple doses in advanced cancer patients | 2005 | 2 |
About Darcy A. Kerr
Darcy A. Kerr is a scholar working on Otorhinolaryngology, Rheumatology and Pathology and Forensic Medicine, having authored 113 papers that have together received 1.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (31 papers), Bone Tumor Diagnosis and Treatments (20 papers), Tumors and Oncological Cases (15 papers), Salivary Gland Tumors Diagnosis and Treatment (14 papers), Thyroid Cancer Diagnosis and Treatment (13 papers), Soft tissue tumor case studies (10 papers), Oral and Maxillofacial Pathology (10 papers) and Head and Neck Cancer Studies (10 papers). The work is most often cited by research in Otorhinolaryngology (138 citations), Rheumatology (266 citations) and Oncology (472 citations). Darcy A. Kerr has collaborated with scholars based in United States, Austria and Switzerland. Frequent co-authors include Andrew E. Rosenberg, Breelyn A. Wilky, Ty K. Subhawong, Jonathan C. Trent, G. Petur Nielsen, Despina S. Kolonias, Konstantinos Linos, Matteo Trucco, Jaime R. Merchan and William C. Faquin. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.